A new study by Virginia Commonwealth University researchers suggests that dysregulation in the way two G protein-coupled receptors talk to each other may be responsible for some symptoms of schizophrenia and could lead to ...
Feb 3, 2016
0
21
Schizophrenia is a complex brain disorder characterized by severe social dysfunctions. A similar but attenuated format of social dysfunction has also been found in individuals with subclinical features such as social anhedonia.
Oct 15, 2021
0
8
The inability to hear subtle changes in pitch, a common and debilitating problem for people with schizophrenia, is due to dysfunctional N-methyl-D-aspartate (NMDA) brain receptors, according to a study by Columbia University ...
Dec 5, 2016
0
38
Structural brain abnormalities in patients with schizophrenia, providing insight into how the condition may develop and respond to treatment, have been identified in an internationally collaborative study led by a Georgia ...
Jul 7, 2015
0
160
The use of weak electrical currents to stimulate the brain is a safe treatment for depression and might even improve attention and reduce pain elsewhere in the body, an Australian study has found.
Mar 6, 2012
1
0
Adolescents diagnosed with schizophrenia and other psychoses appear to show greater decreases in gray matter volume and increases in cerebrospinal fluid in the frontal lobe compared to healthy adolescents without a diagnosis ...
Jan 2, 2012
0
0
A new study by UCLA scientists adds to the understanding of the genetic architecture of schizophrenia.
Jul 9, 2015
0
175
Patients with schizophrenia have higher personal space (PS) size and lower PS permeability compared with controls, according to a study published online June 5 in Schizophrenia Bulletin.
Jul 20, 2022
0
2
A pioneering new study finds that a specific type of computerized cognitive training can lead to significant neural and behavioral improvements in individuals with schizophrenia. The research, published by Cell Press in the ...
Feb 22, 2012
0
0
(HealthDay)—Individuals with schizophrenia are at increased risk for COVID-19 morbidity and mortality versus individuals without schizophrenia, according to a study published in the September issue of Schizophrenia Bulletin.
Sep 27, 2021
0
2
